Sign In
to Vote &
Create Storyboards.
 
(The Francis Crick Institute) A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, a new study suggests.The research, published in Cell Reports, found that lung tumors in mice caused by mutations in a gene called EGFR shrunk significantly when a protein called p110α was blocked.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard